CTIS.eu › Cities › France › Caen Cedex 9
Caen Cedex 9
France
295 total trials
135 recruiting
2022-500536-11-00
5
Moderately to severely active ulcerative colitis
2022-500537-84-00
5
Moderately to severely active ulcerative colitis
2023-507633-21-00
5
Neurological Disease
2024-519922-19-00
4
Neuroendocrine carcinoma of gastro-enteropancreatic or unknown origin
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2023-505469-95-00
10
Primary Sclerosing Cholangitis
2024-512236-30-00
5
Community-acquired alveolar pneumonia in children
2024-513292-40-00
5
Multiple sclerosis
2024-513724-42-00
10
Medulloblastoma
2024-514246-37-00
4
Idiopathic pulmonary fibrosis (IPF)
2024-514838-20-00
5
Type 1 Diabetic patients
2024-515714-40-00
4
Gout adult patients
2024-515834-34-00
5
complicated acute appendicitis
2024-516257-44-00
4
Multiple myeloma
2024-518146-25-00
5
patients with atrial fibrillation and preserved left ventricular eject
2024-518231-11-00
4
Immune thrombocytopenia (ITP)
Warm autoimmune hemolytic anemia (wAIHA
2024-518251-31-00
5
patients hospitalized for a septic shock with hypercontractlity
2024-518653-41-00
5
Patients with giant cell arteritis (= Horton’s disease)
2024-518795-31-00
10
Adult patients (> 18 years of age) undergoing palliative care (defined
2024-519986-23-00
5
The study will involve adult women and men from 16 French centers who
2024-520089-70-00
5
Cutaneous lupus erythematosus
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms
2025-520573-39-00
6
Ultra High Risk of psychosis and first episode psychosis
2025-520632-42-00
5
axial or predominantly axial SpA with or without psoriasis
Showing 1–24 of 295 trials